Design, characterization, and bioactivity evaluation of novel symmetrical N,N'-benzene-1,2-diylbis[1-(2-chloroquinolin-3-yl)methanimine] based metal complexes

This study presents the synthesis and characterization of two novel metal complexes derived from the symmetrical Schiff base N,N'-benzene-1,2-diylbis[1-(2-chloroquinolin-3-yl)methanimine] (OBCQ), coordinated with Nickel(II) (NiOBCQ) and Copper(II) (CuOBCQ). The structural elucidation of these complexes was achieved through a comprehensive suite of analytical techniques, including elemental analysis, UV–visible spectroscopy, mass spectrometry, infrared spectroscopy, magnetic susceptibility, conductivity measurements, and thermal analysis. The data confirm that both NiOBCQ and CuOBCQ adopt octahedral geometries, formulated as [Ni(OBCQ)(H₂O)₂(Cl)₂] and [Cu(OBCQ)(H₂O)₂(Cl)₂], respectively. Density Functional Theory (DFT) calculations were employed to validate the molecular structures and explore the quantum chemical parameters of OBCQ and its metal complexes. Additionally, in vitro assessments of anti-inflammatory and antioxidant activities revealed enhanced bioactivity for the metal complexes compared to the free OBCQ ligand. Molecular docking studies against key proteins (5IKT for Human Cyclooxygenase-2 and 5IJT for Human Peroxiredoxin 2) highlighted strong binding affinities and molecular interactions, suggesting that OBCQ and its metal complexes hold significant promise as novel therapeutic agents with multifaceted biological activities.